Seelos Therapeutics - 53 Year Dividend History | SEEL
Historical dividend payout and yield for Seelos Therapeutics (SEEL) since 1971. The current TTM dividend payout for Seelos Therapeutics (SEEL) as of April 15, 2024 is $0.00. The current dividend yield for Seelos Therapeutics as of April 15, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.006B |
$0.002B |
|
Seelos Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focused on the development and advancement of novel therapeutics to address unmet medical needs for central nervous system disorders. The company's product pipeline consists of SLS-002, SLS-006, SLS-008, SLS-010 and SLS-012 which are in clinical stage. Seelos Therapeutics Inc., formerly known as Apricus Biosciences Inc., is based in New York, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
